اثر شش هفته تمرین هوازی و عصاره دارچین بر بیان ژن اینترلوکین یک بتا در بافت ماهیچهی موش های نر تغذیه شده با رژیم غذایی پرچرب
محورهای موضوعی : فصلنامه زیست شناسی جانوریحسین باخدا 1 , نعمت اله نعمتی 2 , طاهره باقرپور 3
1 - گروه تربیت بدنی و علوم ورزشی، واحد دامغان، دانشگاه آزاد اسلامی، دامغان، ایران
2 - گروه تربیت بدنی و علوم ورزشی، واحد دامغان، دانشگاه آزاد اسلامی، دامغان، ایران
3 - گروه تربیت بدنی و علوم ورزشی، واحد دامغان، دانشگاه آزاد اسلامی، دامغان، ایران
کلید واژه: چاقی, ورزش, دارچین, چاقی, رژیم پرچرب, اینترلوکین یک بتا,
چکیده مقاله :
در افراد چاق، سطح بیان اینترلوکین یک بتا بالاتر است، به طوری که میزان بیان اینترلوکین یک بتا با سطح شاخص توده بدنی و توده چربی ارتباط مثبت مستقیمی دارد. پژوهش حاضر با هدف تعیین اثرات اجرای شش هفته تمرین هوازی، مصرف عصاره دارچین و غذای پرچرب بر بیان ژن اینترلوکین یک بتا در بافت ماهیچه موش های نر تغذیه شده با رژیم غذایی پرچرب با استفاده از موشهای صحرایی نر دو ماهه نژاد ویستار انجام شد تعداد 50 سر موش صحرایی نر دو ماهه پس از دو هفته نگهداری در شرایط کنترل شده به پنج گروه کنترل, رژیم پرچرب، عصاره دارچین و رژیم پرچرب، تمرین هوازی و رژیم پرچرب و تمرین هوازی و عصاره دارچین و رژیم پرچرب تقسیم شدند. عصاره دارچین به میزان 200 میلی گرم به ازائ هر کیلوگرم از وزن بدن و امولسیون غذای پرچرب مازاد بر آب و غذای معمولی جوندگان روزانه به مقدار 5/1 میلی گرم به ازاء هر کیلوگرم از وزن بدن به مدت شش هفته به صورت گاواژ داده شد. گروه تمرین برای پنج روز در هفته و به مدت شش هفته در برنامه تمرین هوازی روی نوارگردان شرکت کردند. میانگین متغیرهای پژوهش در بین گروه ها (بجز گروه کنترل) با هدف تعیین تفاوت های بین گروهی، با آزمون های آنالیز واریانس یک طرفه و بونفرونی مقایسه شدند. میانگین متغیرهای پژوهش در بین هر گروه با گروه کنترل با هدف تعیین تفاوت های درون گروهی، با آزمون آماری تی تک نمونه در سطح معنی داری 05/0 ≥ p مقایسه شدند. تفاوت متغیر وزن بدن در پس آزمون در بین تمامی گروه ها معنی دار بود. تفاوت میانگین های متغیر اینترلوکین یک بتا در بافت ماهیچه موش های نر تغذیه شده با رژیم غذایی پرچرب پس از شش هفته تمرین هوازی، مصرف عصاره دارچین و غذای پرچرب معنی دار بود.
Methotrexate is a chemotherapy drug that is widely used in neoplastic disorders and ectopic pregnancy. In previous research, the toxicity of methotrexate has been reported on the genital tract. The properties of Royal jelly such as impotence improvement, and antioxidant and anticancer function have been reported. Therefore, in the present research, the effect of Royal jelly on ovarian cells in NMRI female mice treated with methotrexate was investigated. In this study, 70 female mice were divided into: negative control (without injection), positive control (received 0.5 mg/kg methotrexate), sham, and three experimental groups (T1, T2, and T3 received methotrexate plus 25, 50 and 100 mg/kg Royal jelly). Intraperitoneal injection was performed for 8 days. After histological processing and staining, the ovarian tissue, primary, secondary and graafian follicles, yellow body, as well the number of generation was investigated. Data were analyzed by Tukey test and one way ANOVA. Results showed there was a significant decrease in the number of generation in positive control, but the number of generation in experimental groups returned to the initial state. Regarding the duration of fertility, there was a significant decrease in the fertility rate in T1 and T3 compared to positive control group. The results of estrogen hormone showed a significant decrease in positive control group compared to negative control and increased significantly in T1 and T2. The number of primary, secondary, and graafian follicles in T 2 and T3 showed a significant increase (P<0.001). According to the present study, it was found that with further investigations, the appropriate dose of Royal jelly could act as a protective agent against the side effects of methotrexate and improve fertility.
- Badalzadeh, R., Shaghaghi, M., Mohammadi, M., Dehghan, G., Mohammadi, Z. 2014. The effect of cinnamon extract and long-term aerobic training on heart function, biochemical alterations and lipid profile following exhaustive exercise in male rats. Advanced Pharmaceutical Bulletin, 4(2): 515-520.
- Bray, G.A. 1998. Contemporary diagnosis and management of obesity: Handbooks in Health Care.
- Carey, A.L., Steinberg, G.R., Macaulay, S.L., Thomas, W.G., Holmes, A.G., Ramm, G., 2006. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes, 55(10): 2688-2697.
- Chao, L.K., Hua, K.F., Hsu, H.Y., Cheng, S.S., Liu, J.Y., Chang, S.T. 2005. Study on the anti-inflammatory activity of essential oil from leaves of Cinnamomum osmophloeum. Journal of Agricultural and Food Chemistry, 53(18): 7274-7278.
- Church, T.S., Thomas, D.M., Tudor-Locke, C., Katzmarzyk, P.T., Earnest, C.P., Rodarte, R.Q. 2011. Trends over 5 decades in US occupation-related physical activity and their association with obesity. PloS one, 6(5): e19657.
- Da Cunha Nascimento, D., de Sousa, N.M.F., de Sousa Neto, I.V., Tibana, R.A., de Souza, V.C., Vieira, D.C.L., 2015. Classification of pro-inflammatory status for interleukin-6 affects relative muscle strength in obese elderly women. Aging Clinical and Experimental Research, 27(6): 791-797.
- Ebrahimi, M., Khenar Sanami, S. 2015. Effects of high fat diet and high intensity aerobic training on interleukin 6 plasma levels in rats. Modares Journal of Medical Sciences: Pathobiology, 18(3): 110-116.
- Eckel, R.H., Grundy, S.M., Zimmet, P.Z., 2005. The metabolic syndrome. The Lancet, 365(9468): 1415-1428.
- Eftekhari, E., Zafari, A., Gholami, M., 2016. Physical activity, lipid profiles and leptin. The Journal of Sports Medicine and Physical Fitness, 56(4): 465-469.
- Fairburn, C.G., Walsh, B.T., 2002. Atypical eating disorders (eating disorder not otherwise specified). Eating Disorders and Obesity: A comprehensive handbook. 2: 171-177.
- Flegal, K.M., Graubard, B.I. 2009. Estimates of excess deaths associated with body mass index and other anthropometric variables. The American Journal of Clinical Nutrition, 89(4): 1213-1219.
- Gadina, M., Hilton, D., Johnston, J.A., Morinobu, A., Lighvani, A., Zhou, Y-J. 2001. signaling by type I and II cytokine receptors: ten years after. Current Opinion in Immunology, 13(3): 363-373.
- Hasani-Ranjbar, S., Nayebi, N., Larijani, B., Abdollahi, M. 2009. A systematic review of the efficacy and safety herbal medicine used in the treatment of obesity. World Journal of Gastroenterology, 15(25): 3073.
- Kumanogoh, A., Ogata, M. 2010. The study of cytokines by Japanese researchers: a historical perspective. International Immunology, 22(5): 341-345.
- Liuzzi, J.P., Lichten, L.A., Rivera, S., Blanchard, R.K., Aydemir, T.B., Knutson, M.D. 2005. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proceeding of the National Academy of Sciences of the United State of America, 102(19): 6843-6848.
- Loos, R.J. 2012. Genetic determinant of common obesity and their value in prediction. Best Practice and Research Clinical Endocrinology and Metabolism, 26(2): 211-226.
- Lukaszewicz, M., Mroczko, B., Szmitkowski, M. 2007. Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease. Polskie Archiwum Medycyny Wewnetrznej, 117(5-6): 247-251.
- Mathew, S., Abraham, T.E. 2006. Studies on the antioxidant activities of cinnamon (Cinnamomum verum) bark extract, through various in vitro models. Food Chemistry, 94(4): 520-528.
- Na, Y.K., Hong, H.S., Lee, W.K., Kim, D.S. 2015. Increased methylation of interleukin 6 gene is associated with obesity in Korean women. Molecules and Cells, 38(5): 452-456.
- Nasery, L., Zafari, A., Banaeifar, A. A., 2015. The response of leptin and lipid parameters related to an aerobic exercise among young athlete and non-athlete women. Indian Journal of Fundamental and Applied Life Sciences, (S3): 788-798.
- Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pederson, B.K. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. The Journal of Clinical Investigation, 113(9): 1271-1276.
- Nguyen, N.T., Magno, C.P., Lane, K.t., Hinojosa, M.W., Lane, J.S. 2008. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: finding from the National Health and Nutrition Examination Survey, 1999 to 2004. Journal of the American College of Surgeon, 207(6): 928-9234.
- Ossanloo, P., Najar, L., Zafari, A. 2012. The effects of combined training (Aerobic dance, step exercise and resistance training) on body fat percent and lipid profiles in sedentary females of Alzahra University. European Journal of Experimental Biology, 2(5): 1598-1602.
- Ouchi, N., Parker, J.L., Lugus, J.J., Walsh, K. 2011. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology, 11(2): 85-97.
- Roussel, A.M., Hininger, I., Benaraba, R., Ziegenfuss, T.N., Anderson, R.A. 2009. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. Journal of the American College of Nutrition, 28(1): 16-21.
- Sartorius, T., Peter, A., Schulz, N., Drescher, A., Bergheim, I., Machann, J. 2014. Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity, PloS one, 9(3): e92358.
- Shalaby, M.A., Saifan, H.A. 2014. some pharmacological effects of cinnamon and ginger herbs in obese diabetic rate. Journal of Intercultural Ethnopharmacology, 3(4): 144.
- Sindhu, S., Thomas, R., Shihab, P., Sriraman, D., Behbahani, K., Ahmad, R. 2015. Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: significance for metabolic inflammation. PloS one, 10(7): e0133494.
- Tanaka, T., Narazaki, M., Kishimoto, T. 2014. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspective in Biology, 6(10): a016295.
- Vieira, V.J., Valentine, R.J., Wilund, K.R., Antao, N., Baynard, T., Woods, J.A. 2009. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. American Journal of Physiology– Endocrinology and Metabolism, 296(5): E1164-1171.